NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Capital expenditures, 2025
- DKK 60.1B
- YoY, 2025
- +27.5%
- 5-year CAGR
- +59.5%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | DKK 60.1B | +27.5% |
| 2024 | DKK 47.2B | +82.8% |
| 2023 | DKK 25.8B | +112.5% |
| 2022 | DKK 12.1B | +91.7% |
| 2021 | DKK 6.3B | +8.8% |
| 2020 | DKK 5.8B | −34.8% |
| 2019 | DKK 8.9B | — |